NCT05741593 Qualitative Analysis of Interviews Between Pharmacist and Elderly Patients Treated with Antithrombotics for an Ischemic Stroke.
| NCT ID | NCT05741593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-04-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cerebrovascular accident is the 2nd leading cause of death and the leading cause of disability in the world. There are brakes and levers of medication adherence in the context of secondary prevention treatment in stroke.
Eligibility Criteria
Inclusion Criteria: * Patients aged 65 and over * Patients hospitalized for an ischemic stroke or a recurrence of ischemic stroke, already being treated with an antithrombotic treatment (antiplatelet agent or anticoagulant ) prior to the stroke * Patients living at home and with a plan to return home. * Patients who did not object to the study and who gave their consent for the recording of the interview Exclusion Criteria: * Patients with cognitive disorders or stroke sequelae that do not allow a semi-directive interview to be carried out (at medical discretion). * Non-French speaking patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05741593 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 100 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05741593 currently recruiting?
Yes, NCT05741593 is actively recruiting participants. Contact the research team at teddy.novais@chu-lyon.fr for enrollment information.
Where is the NCT05741593 trial being conducted?
This trial is being conducted at Villeurbanne, France.
Who is sponsoring the NCT05741593 clinical trial?
NCT05741593 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.